Novo Nordisk’s weight-loss drug Wegovy has received the green light in China, targeting the world’s second-largest economy and the country with the highest number of [more…]
In a surprising turn, Kobayashi Pharmaceutical, the embattled drugmaker at the center of a health scandal involving its beni kōji (red yeast rice) dietary supplements, [more…]
The Thai consulate in Osaka has issued an unusual health advisory for Thai nationals residing or traveling in Osaka, Japan, following the confirmation of measles [more…]
Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]
In a sobering turn of events, Japan has reported its first death from mpox, a viral disease that has been causing concern since its first [more…]
Japan, known for its rich history and advanced technology, is facing a daunting challenge as its population continues to gray and decline. Government data has [more…]
The government’s latest report on karōshi (death from overwork) underscores a pressing need for Japan to make significant strides in enhancing its citizens’ work-life balance. [more…]
In response to increasing reports of health problems linked to quasi-legal drugs in Japan, the government held a closed-door meeting to discuss enhanced regulation and [more…]
According to data from the health ministry, there has been a remarkable 57% increase in the number of newly reported influenza cases at designated medical [more…]
